Paolo Tombesi, Chief Financial Officer at Epizyme, Inc. (EPZM), sold 1,243 shares at $15.28 ($19K) on 2020-03-25, disclosed to the SEC on 2020-03-26.
Scheduled sale ($19k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2020-06-30 | $29K | — | Filing → |